Who owns Abbvie?
- CUSIP Number: 00287Y909
Tip: Access positions for across all investors
Analyze quarterly positions in Abbvie with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Abbvie stock
Who bought or sold Abbvie this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| SG Americas Securities | 991k | $7.8M | -24% | Dec 2025 |
|
| IMC-Chicago | 398k | $91M | -26% | Dec 2025 |
|
| Jpmorgan Chase & Co | 267k | $62M | 100% | Sep 2025 |
|
| Group One Trading | 200k | $46M | -7% | Dec 2025 |
|
| Simplex Trading | 193k | $44M | 4% | Dec 2025 |
|
| Gladius Capital Management | 37k | $8.5M | 145% | Dec 2025 |
|
| Hrt Financial | 36k | $8.2M | -41% | Dec 2025 |
|
| Maven Securities | 15k | $3.5M | -53% | Dec 2025 |
|
| Burns Matteson Capital Management | 1.0k | $64k | 100% | Dec 2025 |
|
| National Bank Of Canada /fi/ | 995.00 | $23M | -50% | Sep 2025 |
|
Who sold out of Abbvie?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Universal- Beteiligungs- und Servicegesellschaft mbH | Sep 2025 | 15k | $3.5M |